Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients

PURPOSE: Change in mammographic density has been suggested to be a proxy of tamoxifen response. We investigated the effect of additional adjuvant systemic therapy and CYP2D6 activity on MD change in a cohort of tamoxifen-treated pre- and postmenopausal breast cancer patients. METHODS: Swedish breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorén, Linda, Eriksson, Mikael, Lindh, Jonatan D., Czene, Kamila, Bergh, Jonas, Eliasson, Erik, Hall, Per, Margolin, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558195/
https://www.ncbi.nlm.nih.gov/pubmed/34570302
http://dx.doi.org/10.1007/s10549-021-06386-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558195/
https://www.ncbi.nlm.nih.gov/pubmed/34570302
http://dx.doi.org/10.1007/s10549-021-06386-2

Ejemplares similares